Germline Mutations for Kidney Volume in ADPKD

Hiroshi Kataoka; Rie Yoshida; Naomi Iwasa; Masayo Sato; Shun Manabe; Keiko Kawachi; Shiho Makabe; Taro Akihisa; Yusuke Ushio; Atsuko Teraoka; Ken Tsuchiya; Kosaku Nitta; Toshio Mochizuki

doi:10.1016/j.ekir.2021.12.012

Germline Mutations for Kidney Volume in ADPKD

Kidney Int Rep. 2021 Dec 13;7(3):537-546. doi: 10.1016/j.ekir.2021.12.012. eCollection 2022 Mar.

Authors

Hiroshi Kataoka^{1

2}, Rie Yoshida¹, Naomi Iwasa¹, Masayo Sato¹, Shun Manabe¹, Keiko Kawachi¹, Shiho Makabe¹, Taro Akihisa¹, Yusuke Ushio¹, Atsuko Teraoka¹, Ken Tsuchiya³, Kosaku Nitta¹, Toshio Mochizuki^{1

2}

Affiliations

¹ Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
² Clinical Research Division for Polycystic Kidney Disease, Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
³ Department of Blood Purification, Tokyo Women's Medical University, Tokyo, Japan.

Abstract

Introduction: Valid prediction models or predictors of disease progression in children and young patients with autosomal dominant polycystic kidney disease (ADPKD) are lacking. Although total kidney volume (TKV) and Mayo imaging classification are generally used to predict disease progression in patients with ADPKD, it remains unclear whether germline mutation types are associated with these factors. We therefore investigated the association between mutation type and TKV and Mayo imaging classification among patients with ADPKD.

Methods: A total of 129 patients with ADPKD who underwent genetic analyses were enrolled in the study. The associations between the severity of PKD (TKV ≥ 1000 ml and Mayo classes 1C-1E) and the PKD1 mutation types (nonsense mutation, frameshift or splicing mutation, and substitution) were evaluated.

Results: Among the mutation types, only PKD1 splicing/frameshift mutation had significant associations with TKV ≥ 1000 ml in sex-adjusted and multivariable logistic analyses. Similarly, only the PKD1 splicing/frameshift mutation was significantly associated with Mayo 1C-1E in sex-adjusted and multivariable logistic analyses. PKD1 nonsense mutation, PKD1 substitution, or PKD1 mutation position had no significant association with TKV ≥ 1000 ml or Mayo 1C-1E.

Conclusion: Kidney cyst severity differs according to the mutation types in PKD1. Patients with PKD1 splicing mutations or PKD1 frameshift mutations are associated with TKV ≥ 1000 ml or Mayo 1C-1E. Detailed assessment of mutation types may be useful for predicting renal prognosis in patients with ADPKD and may especially contribute to the care of a high-risk group of children with ADPKD.

Keywords: Mayo imaging classification; autosomal dominant polycystic kidney disease; frameshift mutation; germline mutation; kidney volume; splicing mutation.